Acute Respiratory Failure

Published on 26/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 1.8 (4 votes)

This article have been viewed 2893 times

9 Acute Respiratory Failure

Acute respiratory failure is one of the leading causes of admission to an intensive care unit (ICU). Behrendt et al. reported that the incidence of acute respiratory failure requiring hospitalization was 137 per 100,000 population in the United States, and the median age of the patients was 69 years.1 More recently, Ray et al. reported that 29% of patients presenting to an emergency department (ED) with acute respiratory failure require admission to an ICU.2

Acute respiratory failure can be secondary to either a failure of oxygenation (hypoxic respiratory failure), a failure of elimination of carbon dioxide (hypercarbic respiratory [ventilatory] failure), or both problems simultaneously. Chronic obstructive pulmonary disease (COPD) with acute exacerbation is the most common cause of ventilatory failure requiring ICU admission.

image Causes of Hypoxic Respiratory Failure

image Hypercarbic Respiratory Failure

PaCO2 is inversely proportional to alveolar ventilation; thus, PaCO2 increases when the elimination of carbon dioxide is decreased because of a decrease in minute ventilation. PaCO2 also increases if minute ventilation remains constant but carbon dioxide production increases. Primary pulmonary diseases are the most common cause of hypercarbia, although nonpulmonary causes contribute to hypoventilation, increased PaCO2, and the need for mechanical ventilatory support.

Minute ventilation can be decreased owing to pulmonary or nonpulmonary factors. Pulmonary causes of impaired minute ventilation include large airway obstruction (e.g., due to the presence of a foreign body or laryngeal spasm), small airway obstruction (e.g., bronchospasm), and destruction of lung parenchyma (e.g., emphysema). Extrapulmonary causes of hypercarbia include neurologic and muscular problems. Neurologic problems include depression of central respiratory drive due to the pharmacologic effects of narcotics or sedatives; depression of respiratory drive as a consequence of stroke, intracranial hemorrhage, or head trauma (i.e., central alveolar hypoventilation); and impaired neuromuscular transmission due to phrenic nerve injury or spinal cord injury (C5 or higher), Guillain-Barré syndrome, myasthenia gravis, or the polyneuropathy of critical illness. Muscular weakness or skeletal abnormalities can cause a decrease in tidal volume and minute ventilation. Causes of hypoventilation secondary to musculoskeletal abnormalities are prolonged use of neuromuscular blocking agents, malnutrition, hypomagnesemia, hypokalemia, hypophosphatemia, kyphoscoliosis, rib fractures, and flail chest, to name several.

In rare cases, hypercarbia can be secondary to increased carbon dioxide production and relative hypoventilation due to overfeeding, since fat synthesis increases the rate of carbon dioxide production relative to the rate of oxygen consumption (respiratory quotient >1.0). Hypermetabolism, such as occurs with high fever or thyrotoxicosis, also is associated with increased carbon dioxide production and (in the setting of already impaired minute ventilation) can exacerbate hypercarbia.

image Clinical Presentation

Dyspnea is the most common symptom associated with acute respiratory failure. Dyspnea is usually associated with rapid shallow breathing and the use of accessory respiratory muscles. Active use of the accessory muscles of respiration during expiration is indicative of impaired airflow during exhalation, a common problem in patients with COPD.

The investigations to evaluate the causes of respiratory failure depend on the suspected mechanism of acute respiratory failure and the primary disease process. Pulse oximetry is a useful monitoring tool and should be carried out in all cases. Other worthwhile diagnostic studies include:

Other more specialized tests (e.g., computed tomography, cultures) are needed based on the differential diagnosis for the suspected primary disease.

image Management

The goal is to maintain adequate oxygenation and ventilation and treat the primary cause of respiratory failure. For hypoxic respiratory failure, the primary goal is to improve arterial oxygenation. In most cases, a reasonable goal is to maintain PaO2 above 65 to 70 mm Hg and arterial blood oxygen saturation (SaO2) above 90%. In very severe cases of hypoxi respiratory failure, efforts to achieve these indices of arterial oxygenation will require interventions, namely very high airway pressures during mechanical ventilation and delivery of 100% oxygen in the inspired gas—interventions that can further damage the lung. Accordingly, in rare instances, it may be prudent to tolerate lower SaO2 values rather than using ventilator settings that could exacerbate lung damage.

Administration of supplemental oxygen will improve oxygenation in most clinical situations except in the presence of a true shunt. Low-flow oxygen can be delivered using a nasal canula or a face mask. The maximum FIO2 that can be delivered using these approaches is about 0.4. This level of oxygen supplementation is inadequate when the alveolar-arterial (A-a) PO2 gradient is very wide. The FIO2 in the inspired gas delivered using a nasal canula or face mask is a function of minute ventilation. When minute ventilation is high, the FIO2 in the inspired gas delivered using a nasal canula or face mask is lower than when minute ventilation is lower. Accordingly, low-flow methods of providing supplemental oxygen should be used cautiously in patients who are dependent on hypoxic drive or have very high minute ventilation. A higher FIO2 can be provided if a face mask is combined with a reservoir bag, because contamination of the inspired gas mixture with room air is minimized.

Noninvasive positive pressure ventilation (NIPPV) and mechanical ventilation via an endotracheal tube are two approaches for providing supplemental oxygen and, at the same time, providing partial or total support for minute ventilation (i.e., decreasing the work of breathing). In hemodynamically stable patients with mild or moderate respiratory failure, NIPPV may decrease the need for intubation and mechanical ventilation and decrease the patient’s length of stay in the ICU.4,5 NIPPV should not be used in patients with altered mental status, who are unable to protect the airway, or for patients who are unable to clear secretions adequately. For some patients, tolerance for NIPPV can be improved by using a nasal mask and starting at a lower level of inspiratory pressure (5 cm H2O).

In cases of hypercarbic respiratory failure, the primary goal of treatment is to maintain arterial pH above 7.32 with a PaCO2 appropriate for the pH.6 In the absence of marked acidemia or hypoxemia, hypercarbia is well tolerated. Accordingly, it may be preferable under some circumstances to accept PaCO2 values that are abnormally high (e.g., >45 mm Hg) rather than risk damaging (or further damaging) the lungs with ventilator settings that promote excessive shear stress within the pulmonary parenchyma.

Bronchodilators can be delivered as metered dose inhalers or nebulizers. Patients with tachypnea and respiratory distress may not be able to use metered dose inhalers. The bronchodilating effects of β-adrenergic agonists and anticholinergic drugs are synergistic. Long-acting β-adrenergic agonists should not be used to treat acute exacerbations of chronic bronchospasm. Corticosteroids are often used to treat acute exacerbations of diseases associated with airway inflammation and bronchospasm (e.g., asthma, COPD). Intravenous methylprednisolone (40 mg IV every 12 hours to 125 mg IV every 6 hours) is often employed if the response is inadequate to initial efforts using bronchodilator treatments with β-adrenergic agonists and anticholinergic agents. Aerosolized steroids may not improve bronchospasm during the acute episode but are useful for maintenance treatment. Patients who experience changes in the nature of the sputum and signs of infection may benefit from a short course (7–10 days) of antibiotic therapy.

The use of NIPPV in hemodynamically stable patients with mild to moderate ventilatory failure may decrease the need for mechanical ventilatory support and length of stay. The precautions while using NIPPV are the same as listed previously.

Intubation And Mechanical Ventilation

The need for mechanical ventilatory support is a clinical decision based on increased work of breathing (i.e., respiratory rate >35/min, use of accessory muscles of ventilation) and inability to clear secretions, and maintain a patent, protected, adequate airway. The clinician has only two basic maneuvers for improving PaO2 using mechanical ventilation. The first is to increase FIO2. The second is to increase mean airway pressure. The latter goal can be achieved primarily in two ways: (1) application of positive end-expiratory pressure (PEEP) or (2) changing the duty cycle so that the duration of inspiration is longer (in the extreme, this maneuver is called inverse ratio ventilation). In patients with acute lung injury, tidal volume should be limited to 6 mL/kg (ideal body weight).7 Prone positioning, high-frequency oscillatory ventilation, inhaled nitric oxide, differential lung ventilation, and transtracheal gas insufflation have been shown to improve arterial oxygenation in selected patients with profound hypoxemia due to acute lung injury, but none of these approaches has been shown to improve survival.

Ventilation should be adjusted to maintain pH and PaCO2 at levels that are appropriate for the patient, particularly in patients with COPD and chronic respiratory acidosis. Hyperventilation and excessive correction of PaCO2 in patients with chronic respiratory acidosis results in secondary metabolic alkalosis and delay in weaning from mechanical ventilation. Alveolar air trapping (so-called auto-positive end-expiratory pressure) and hypotension (due to impaired venous return) may develop in patients with inadequate exhalation time, and caution should be used when increasing minute ventilation by increasing either ventilator-delivered respiratory rate or tidal volume in patients with severe airway obstruction.

Annotated References

ARDSnet. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301-1308.

First ROCT to show outcome benefit in ventilation strategy in patients with ARDS.

Behrendt CE. Acute respiratory failure in the United States: incidence and 31-day survival. Chest. 2000;118(4):1100-1105.

Provides excellent epidemiology data for acute respiratory failure in the United States.

Chelluri L. Critical illness in the elderly: review of pathophysiology of aging and outcome of intensive care. J Intensive Care Med. 2001;16:114-127.

Reviews specific factors affecting prognosis in the elderly.

Dakin J, Griffiths M. The pulmonary physician in critical care 1: pulmonary investigations for acute respiratory failure. Thorax. 2002;57:79-85.

Good review of bedside clinical evaluation tools in assessing etiology of acute respiratory failure.

Hill NS, Brennan J, Garpestad E, Nava S. Noninvasive ventilation in acute respiratory failure. Crit Care Med. 2007;35(10):2402-2407.

Informative review of use of NIV for primarily medical causes of ARF.

Jaber S, Chanques G, Jung B. Postoperative noninvasive ventilation. Anesthesiology. 2010;112(2):453-461.

Discusses recent advances in use of NIPPV in postoperative patients with ARF.

MacIntyre N, Huang YC. Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):530-535.

Reviews latest diagnostic, prognostic data and treatments for acute exacerbations of COPD.

Ray P, Birolleau S, Lefort Y, Becquemin MH, Beigelman C, Isnard R, et al. Acute respiratory failure in the elderly: etiology, emergency diagnosis and prognosis. Crit Care. 2006;10(3):R82.

Although a European study, sheds light on important factors influencing diagnosis and admission to ICU.